TD Cowen Maintains Buy on Ovintiv, Raises Price Target to $60

TD Cowen analyst Robert Hodges has maintained a 'Buy' rating on Ovintiv (NYSE: OVV) and increased the price target from $58 to $60. This adjustment reflects a positive outlook for the company in the market.